Mega VC raises land

A split is opening inside artificial intelligence investing, and it showed up this week in two very different fund announcements. Eclipse Ventures said on April 7, 2026 that it had raised $1.3 billion across two funds, while Zero Shot Fund said it is building a $100 million vehicle for much earlier bets. (eclipse.capital) (zeroshotfund.com) Those two numbers matter because they aim at opposite ends of the startup timeline. Eclipse is writing checks for companies that need factories, supply chains, and long build cycles, while Zero Shot is chasing founders when the company may still be little more than an idea and a few engineers. (eclipse.capital) (techcrunch.com) Eclipse did not raise one giant pool. It closed Eclipse Fund VI at $720 million and Early Growth Fund III at $591 million, bringing the firm’s total assets under management to about $10 billion. (eclipse.capital) The firm says it wants to build what it calls “physical industries,” which means software tied to machines, power systems, logistics networks, and defense programs instead of software that lives only on a laptop screen. Its recent areas of focus include artificial intelligence infrastructure, manufacturing, transportation, energy, compute, and defense. (eclipse.capital) (techcrunch.com) That kind of investing is expensive in a way consumer software usually is not. A chatbot startup can launch with rented cloud servers, but a robotics company or battery materials company may need warehouses, custom hardware, regulatory work, and years of testing before revenue arrives. (techcrunch.com) Eclipse is also betting that these companies work better as a cluster than as isolated projects. In its announcement, the firm described its portfolio as a connected industrial network in which startups share infrastructure, customers, talent, and operating knowledge. (eclipse.capital) That strategy fits the kinds of companies Eclipse already backs. TechCrunch reported that its investments include Redwood Materials in battery recycling, Wayve in autonomous driving, Bedrock Robotics in construction vehicles, Arc in electric boats, and Mind Robotics in industrial robotics. (techcrunch.com) The other side of the market looks almost nothing like that. Zero Shot Fund says it is a $100 million fund “anchored by OpenAI alumni,” and its website says it wants to back founders across robotics, energy, automation, education, artificial intelligence security, and biology. (zeroshotfund.com) TechCrunch reported on April 6, 2026 that Zero Shot has already made a first close on its $100 million target and has already written a few checks. The founding team includes former OpenAI leaders Evan Morikawa, Andrew Mayne, and Shawn Jain, along with Kelly Kovacs and Brett Rounsaville. (techcrunch.com) Zero Shot is selling a different advantage than Eclipse. Instead of promising deep capital for long industrial buildouts, it is promising technical judgment from people who helped build and launch ChatGPT, the OpenAI application programming interface, and Code Interpreter, and who say founders come to them when product and model decisions are still being formed. (zeroshotfund.com) That creates a two-track market in artificial intelligence venture capital. One track is getting larger and more capital-intensive as investors fund data centers, robotics, manufacturing tools, and defense-related systems; the other is staying small and specialized so it can move early, before a category is obvious and before a company needs hundreds of millions of dollars. (eclipse.capital) (zeroshotfund.com) (techcrunch.com) The bigger signal is not just that more money is flowing into artificial intelligence. It is that limited partners, the pension funds, endowments, family offices, and institutions that supply venture capital firms with money, appear willing to fund both the heavy industrial end of the market and the fast-moving seed end at the same time. That is how you get a $1.3 billion hard-tech raise and a new $100 million specialist fund in the same week. (eclipse.capital) (techcrunch.com) If that pattern holds, the artificial intelligence startup pipeline may start to look more like the pharmaceutical industry than the old software market. Small specialist funds will hunt for raw ideas at the lab stage, and giant firms will step in later when the winners need expensive infrastructure, manufacturing capacity, and years of scaling support. That is an inference from the structures these two firms just announced, not a statement either firm made directly. (eclipse.capital) (zeroshotfund.com) (techcrunch.com) For founders, that means the fundraising question is changing from “Can I raise for artificial intelligence?” to “Which artificial intelligence capital pool fits the kind of company I am building?” A model tool, workflow software product, or early research team may fit Zero Shot’s world, while a robotics, defense, energy, or factory-scale company may need the kind of balance sheet Eclipse just assembled. (zeroshotfund.com) (techcrunch.com)